½ÃÀ庸°í¼­
»óǰÄÚµå
1351239

»çȸ°æÁ¦Àû ¹ßÀü : ÇコÄɾîÀÇ ¼ºÀå ±âȸ

Socioeconomic Development: Healthcare Growth Opportunities

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 62 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µðÁöÅÐÈ­, Á¤Ã¥ ÃßÁø, ÇöÁö »ý»êÀÌ ÇコÄÉ¾î ¹× °ü·Ã ºÐ¾ßÀÇ ¼ºÀå ±âȸ¸¦ °ßÀÎ

°æÁ¦ Àü¸ÁÀº ºÎÁøÇÏÁö¸¸, 2023³â¿¡µµ ¼¼°è ÇコÄÉ¾î »ê¾÷Àº °ß°íÇÑ ½ÅÈï½ÃÀå ¼ºÀå, ÆÒµ¥¹Í ÀÌÈÄ °Ç°­ Á᫐ Á¤Ã¥ °­È­, ÁÖ¿ä ¼±Áø±¹ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ­, R&D ºñ¿ë Áõ°¡¿¡ ÈûÀÔ¾î ¹àÀº Àü¸ÁÀ» À̾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü°ú µðÁöÅÐ Çõ½ÅÀº ȯÀÚ °á°ú¿Í ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¸¶Áö¸· 1¸¶ÀÏ Á¢±ÙÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÎÇ÷¹ÀÌ¼Ç ¾Ð·Â, ÅëÈ­Á¤Ã¥ÀÇ ±äÃà, ÀÇ·á Áغñ °­È­ ¿ä±¸·Î ÀÎÇØ ±â¾÷°ú Á¤ºÎ´Â ±â¼ú°ú Çõ½ÅÀû Á¢±Ù ¹æ½Ä¿¡ ÅõÀÚÇϰí ÀÌ ºÐ¾ßÀÇ Àå±âÀûÀÎ ¼º°ú¸¦ Çâ»ó½Ãų ¼ö ÀÖ´Â Á¤Ã¥ °³Çõ¿¡ Âø¼öÇØ¾ß ÇÕ´Ï´Ù.

ÀÌ·¯ÇÑ »óȲ¿¡¼­ ÇÁ·Î½ºÆ® ¾Ø ¼³¸®¹øÀº Áöǥȭ ±â¹ýÀ» Ȱ¿ëÇØ ¸Å³â Àü ¼¼°è ÇコÄÉ¾î ½ÃÀåÀÇ °æÀï·ÂÀ» ÃßÀûÇϰí ÀÖ½À´Ï´Ù. ¼ºÀå, Çõ½Å, ¸®´õ½ÊÀ» ÅëÇÑ ÇコÄÉ¾î ¸Å·Âµµ Áö¼ö(GIL-H Áö¼ö)´Â ¼ºÀå(G), Çõ½Å(I), ¸®´õ½Ê(L), ÇコÄɾî(H)ÀÇ ³× °¡Áö ÁöÇ¥·Î ±¸¼ºµÈ ¿©·¯ ÁöÇ¥¸¦ ÅëÇØ °¢ ±¹°¡¸¦ Æò°¡Çϰí, °­·ÂÇÑ µ¥ÀÌÅÍ ±â¹Ý Á¢±Ù ¹æ½ÄÀ» ÅëÇØ À¯¸ÁÇÑ ÇコÄɾî ÁøÃâ Áö¿ªÀ» ÆÄ¾ÇÇÕ´Ï´Ù. ÆÄ¾ÇÇÕ´Ï´Ù. °­·ÂÇÑ ±¹°¡º° ¼øÀ§ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ¹Ì°³Ã´ ½ÃÀå¿¡ ´ëÇÑ Áö½ÄÀ» ¾ò°í, À̸¦ ÅëÇØ ´õ ¸¹Àº ¼öÀÍÀ» âÃâÇÏ°í ºñÁö´Ï½º¸¦ È®ÀåÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ±â¾÷ÀÌ Àü ¼¼°è¿¡ ¹ßÀÚÃ븦 ³²±â´Â °¡¿îµ¥, Á¤ºÎ´Â ¿Ü±¹ÀÎ ÅõÀÚ¸¦ À¯Ä¡ÇÏ°í ¼Òµæ ¼öÁØÀ» ³ôÀ̰í ÀÏÀÚ¸®¸¦ âÃâÇÒ ¼ö ÀÖ´Â ÀÚ±¹ÀÇ ´É·ÂÀ» È«º¸ÇØ¾ß ÇÒ Àǹ«°¡ ÀÖ½À´Ï´Ù.

ÀÌ µ¥ÀÌÅÍ ±â¹Ý µµ±¸¸¦ ÅëÇØ ÇコÄÉ¾î »ê¾÷ Âü¿©ÀÚµéÀº Àα¸, °æÁ¦ ¼ºÀå°ú °°Àº ±Ô¸ð °ü·Ã ÁöÇ¥¿Í ¼÷·ÃµÈ Àη °¡¿ë¼º, ±³À° ÁöÃâ, ƯÇã Ãâ¿ø µîÀ» ÅëÇØ ÇØ´ç ±¹°¡ÀÇ Çõ½Å »ýŰ踦 Æò°¡ÇÔÀ¸·Î½á ÁøÃâ È帱¹ÀÇ ÆÄÀÌÇÁ¶óÀÎÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹°·ùÀÇ È¿À²¼º°ú Á¤Ä¡Àû ¾ÈÁ¤¼ºÀ» ÅëÇØ ºñÁö´Ï½º ȯ°æµµ ºÐ¼®ÇÕ´Ï´Ù. 50°³ ÀÌ»óÀÇ ÁöÇ¥¸¦ ÅëÇØ ¼øÀ§¸¦ ¸Å±é´Ï´Ù.

2023³â GIL-H Áö¼ö´Â ¸í¸ñ GDP(10¾ï ´Þ·¯, 2019³â IMF Àü¸ÁÄ¡ ±âÁØ)°¡ 200¾ï ´Þ·¯ ÀÌ»óÀÎ 117°³±¹À» ´ë»óÀ¸·Î ¸Å·Âµµ¸¦ ±âÁØÀ¸·Î ¼øÀ§¸¦ ¸Å±é´Ï´Ù. ÀÌ Áö¼ö´Â G, I, L, HÀÇ ±âµÕ°ú ±× ¾Æ·¡ ±¸Ã¼ÀûÀÎ ÁöÇ¥¿¡ °¡ÁßÄ¡¸¦ ºÎ¿©ÇØ ±¹°¡º° ¼øÀ§¸¦ ¸Å±é´Ï´Ù. ÃËÁø¿äÀΰú °úÁ¦¸¦ °­Á¶ÇÏ´Â ¾ö¼±µÈ ±¹°¡º° ÇÁ·ÎÇÊÀº µ¥ÀÌÅÍ ¸ðµ¨À» º¸¿ÏÇÕ´Ï´Ù.

Áö¿ª ºÐ·ù

  • ¾ÆÇÁ¸®Ä«: 19°³ ±¹°¡
  • ¾Æ¸Þ¸®Ä«: 21°³ ±¹°¡
  • ¾Æ½Ã¾ÆÅÂÆò¾ç: 23°³ ±¹°¡
  • Áß¾Ó¾Æ½Ã¾Æ : 5°³ ±¹°¡
  • µ¿À¯·´: 19°³ ±¹°¡
  • Áßµ¿: 13°³ ±¹°¡
  • ¼­À¯·´ : 17°³ ±¹°¡

¸ñÂ÷

Àü·«Àû °úÁ¦

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
  • The Strategic Imperative 8(TM)
  • ÇコÄÉ¾î ¹× °ü·Ã »ê¾÷ÀÇ Àü·«Àû Áß¿ä °úÁ¦ »óÀ§ 3°³ ÀÓÆÑÆ®
  • Growth Pipeline Engine(TM)À» ÁöÁöÇÏ´Â ¼ºÀå ±âȸ

¼¼°è °æÁ¦ ȯ°æ

  • ¼¼°è °æÁ¦ ȯ°æ : °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ÀúÇØ¿äÀÎ

¼ºÀ塤Çõ½Å¡¤¸®´õ½Ê¡¤ÇコÄɾî(GIL-H) ÇÁ·¹ÀÓ¿öÅ©¿Í Á¶»ç ¹æ¹ý

  • ±¹°¡º° ¼øÀ§ ÇÁ·¹ÀÓ¿öÅ©ÀÇ Çʿ伺
  • ÇÁ·Î½ºÆ®&¼³¸®¹Ý µ¶ÀÚÀûÀÎ GIL ÇÁ·¹ÀÓ¿öÅ©¿Í GIL-HÀ妽º ¼­·Ð
  • Áö¿ªº° ¹× GDP °èÃþº° ±¹°¡º° Ä¿¹ö¸®Áö
  • Á¶»ç ¹æ¹ý
  • GIL-HÁö¼ö Ȱ¿ë ½ÉÇÃÇÑ 3 ½ºÅÜ
  • GIL-HÁö¼ö 2023À¸·Î »ç¿ëµÇ°í ÀÖ´Â ÁöÇ¥

Á¶»ç °á°ú

  • GIL-H 2023³â °á°ú
  • GIL-H 2023³â °á°ú ÇØ¼³
  • Áß±¹
  • ¹Ì±¹
  • Àεµ
  • ½ºÀ§½º
  • ÀϺ»

°¢±¹ÀÇ »ç·Ê ¿¬±¸

  • Áß±¹
  • »ç¿ìµð¾Æ¶óºñ¾Æ(KSA)
  • ¸ß½ÃÄÚ

¼ºÀå ±âȸ À¯´Ï¹ö½º

  • ¼ºÀå ±âȸ 1 : µðÁöÅÐ Àüȯ
  • ¼ºÀå ±âȸ 2 : ¼¼°èÀÇ »ýȰ½À°üº´ Áõ°¡
  • ¼ºÀå ±âȸ 3 : ½ÅÈï ½ÃÀåÀÇ À¯´Ï¹ö¼³¡¤Çコ¡¤Ä¿¹ö¸®Áö
  • ¼ºÀå ±âȸ 4 : ½ÅÈï ½ÃÀåÀÇ ·ÎÄø®Á¦ÀÌ¼Ç ±âȸ
  • ¼ºÀå ±âȸ 5 : °æÁ¦ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ­

ºÎ·Ï

  • GIL-HÁö¼ö
  • GIL-HÁö¼ö 2023À¸·Î »ç¿ëµÇ´Â ÁöÇ¥
  • ±¹°¡º° ¸®½ºÆ®, GIL-HÁö¼ö, 2023³â
  • ¼¼°è °á°ú
  • Áö¿ªº° °á°ú ¾ÆÇÁ¸®Ä«, ¾Æ¸Þ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áö¿ªº° °á°ú ¾Æ½Ã¾ÆÅÂÆò¾ç, Á߾ӾƽþÆ, µ¿À¯·´, Áßµ¿, ¼­À¯·´
  • GDP ºê·¡Å¶º° ¼¼°è °á°ú
  • µµÇ¥
  • ¸éÃ¥»çÇ×
ksm 23.10.30

Digitalization, Policy Impetus, and Localized Manufacturing Drive Growth Opportunities in the Healthcare and Allied Sectors

Despite a subdued economic outlook, 2023 is forecast to remain upbeat for the global healthcare industry, supported by steady emerging market growth, increased post-pandemic health-centric policies, rapidly aging populations in major developed nations, and higher R&D spending. Rapid technological advancements and digital transformation are improving patient outcomes and last-mile access to healthcare. Amid the inflationary pressures, tighter monetary policy environments, and the need for increasing healthcare preparedness, corporations and governments need to invest in technologies and innovative approaches and initiate policy reforms that boost the sector's long-term performance.

Given these conditions, Frost & Sullivan leverages an indexing methodology to track the competitiveness of healthcare markets across the globe annually. The Growth, Innovation, and Leadership Index for Healthcare Attractiveness (GIL-H Index) identifies go-to destinations for healthcare using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L), and Healthcare (H) pillars. A robust country ranking framework is vital for companies to gain knowledge of untapped markets into which they can expand, generate more revenue, and scale up operations. With corporates building their footprint globally, governments are tasked with showcasing their country's ability to attract foreign investment, raise income levels, and create jobs.

This data-driven tool allows healthcare industry participants to build their go-to country pipeline by evaluating size-related indicators (e.g., population and economic growth) and the country's innovation ecosystem through skilled labor availability, education expenditure, and patent applications. It also analyzes the business environment through logistics efficiency and political stability. The ranking process uses more than 50 indicators.

The 2023 GIL-H Index ranks 117 countries with nominal GDP ($ billion, based on IMF projection for 2019) at or above $20 billion based on their attractiveness. The index generates country rankings, following the assignment of weights to the G, I, L, and H pillars and the specific indicators under them. Selected country profiles highlighting drivers and challenges supplement the data model.

Regional classification:

  • Africa: 19 countries
  • Americas: 21 countries
  • Asia-Pacific: 23 countries
  • Central Asia: 5 countries
  • Eastern Europe: 19 countries
  • Middle East: 13 countries
  • Western Europe: 17 countries

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Healthcare and Allied Industries
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Global Economic Environment

  • Global Economic Environment: An Overview
  • Growth Drivers
  • Growth Restraints

Growth Innovation Leadership Healthcare (GIL-H) Framework and Methodology

  • The Need for a Country Ranking Framework
  • Frost & Sullivan's Proprietary GIL Framework and Introduction to GIL-H Index
  • Country Coverage by Region and GDP Bracket
  • Research Methodology
  • Using GIL-H Index: A Simple 3-step Process
  • Indicators Used in the GIL-H Index 2023

Results

  • GIL-H 2023 Results
  • GIL-H 2023 Results Explained
  • China
  • United States
  • India
  • Switzerland
  • Japan

Country Case Studies

  • China
  • Kingdom of Saudi Arabia (KSA)
  • Mexico

Growth Opportunity Universe

  • Growth Opportunity 1: Digital Transformation
  • Growth Opportunity 2: Global Rise of Lifestyle Diseases
  • Growth Opportunity 3: Universal Health Coverage in Emerging Markets
  • Growth Opportunity 4: Localization Opportunities in Emerging Markets
  • Growth Opportunity 5: Rapidly Aging Economies

Appendix

  • GIL-H Index
  • Indicators Used in the GIL-H Index 2023
  • Country List, GIL-H Index, 2023
  • Global Results
  • Regional Results: Africa, Americas, Asia-Pacific
  • Regional Results: Asia-Pacific, Central Asia, Eastern Europe, Middle East, Western Europe
  • Global Results by GDP Bracket
  • List of Exhibits
  • Legal Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦